[{"Assets_0_Q3_USD":"11301633000.0","CIK":"875320","CommonStockSharesConverted_0_Q3_shares":"260174000.0","CommonStockSharesOutstanding_0_Q3_shares":"260174000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"2.56","EarningsPerShareBasic_3_Q3_USD":"8.1","EarningsPerShareDiluted_1_Q3_USD":"2.53","EarningsPerShareDiluted_3_Q3_USD":"7.98","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"2761973000.0","NetIncomeLossConverted_1_Q3_USD":"667434000.0","NetIncomeLossConverted_3_Q3_USD":"2107457000.0","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q3_USD":"1538271000.0","RevenuesConverted_3_Q3_USD":"4577863000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q3_USD":"8133473000.0","Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"264079000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"264031000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"260392000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"260313000.0","filed":"20201030","footnote":null,"form":"10-Q","fp":"Q3","fy":"2020.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20200930","qtrs":"3","uom":"USD"}]